What Makes Directly Compressible (DC) Granules a Competitive Advantage in Tablet Manufacturing?

What Makes Directly Compressible (DC) Granules a Competitive Advantage in Tablet Manufacturing?

Posted by

The pressure to manufacture faster, better, and more efficiently

In today’s pharmaceutical landscape, tablet manufacturers are constantly balancing speed, cost, and quality. Every additional processing step adds complexity, increases costs, and introduces variability.

Traditional wet granulation, while effective, comes with its own set of challenges longer processing times, higher energy consumption, and multiple validation checkpoints.

So the question becomes:
Is there a smarter, more efficient way to manufacture tablets without compromising on quality?

The answer lies in Directly Compressible (DC) granules.

Understanding DC Granules beyond the basics

Directly compressible granules are engineered to be compressed into tablets without the need for wet granulation. But they’re not just about skipping a step they fundamentally transform how tablet manufacturing works.

For manufacturers, this means:

  • Simplified production workflows
  • Reduced dependency on multiple processing stages
  • Better control over final tablet quality

However, not all DC granules are created equal. Their performance depends heavily on how they are manufactured.

The role of advanced granulation technology

At Farmson Basic Drugs, the difference begins at the manufacturing stage.

Our DC plant uses fully integrated GLATT granulation technology, a globally trusted system used by leading pharmaceutical manufacturers.

This is not just about equipment it’s about precision.

GLATT technology enables:

  • Uniform particle size distribution
  • Controlled density and flow properties
  • Consistent granule structure

The result is a product that performs reliably across batches and scales seamlessly from development to commercial production.

What “directly compressible” really means for manufacturers

When DC granules are engineered correctly, they do more than simplify processes they create measurable operational advantages.

1. Eliminating wet granulation steps

By removing the need for wet granulation, manufacturers can:

  • Reduce processing time
  • Minimise moisture-related challenges
  • Simplify validation processes

This leads to a more streamlined and predictable production cycle.

2. Reduced equipment and energy requirements

Fewer steps mean:

  • Lower capital investment in machinery
  • Reduced utility consumption
  • Lower operational costs

Over time, this translates into significant efficiency gains.

3. Tighter batch-to-batch consistency

Consistency is critical in pharmaceutical manufacturing.

Well-engineered DC granules ensure:

  • Uniform flow during compression
  • Consistent tablet weight and hardness
  • Reduced variability across batches

This reliability supports regulatory compliance and product quality assurance.

4. Faster time-to-tablet

Speed matters, especially in high-demand therapeutic categories like analgesics.

With DC granules:

  • Production cycles are shorter
  • Scale-up is smoother
  • Time-to-market is improved

For manufacturers, this means responding faster to demand without compromising quality.

Farmson’s Paracetamol DC Granules: Built for performance

Farmson offers a comprehensive range of Paracetamol / Acetaminophen DC granules, including:

  • 83.33% Granules
  • 84.20% Granules
  • 90% Granules
  • 96% Granules
  • 97% Granules

Each grade is carefully designed for drum-to-feeder compression, ensuring seamless integration into modern tablet manufacturing lines.

More importantly, customization is available, allowing manufacturers to tailor granules based on specific formulation and process requirements.

Why manufacturing capability matters

In the world of APIs and intermediates, sourcing isn’t just about availability it’s about reliability and control.

Farmson’s strength lies in its manufacturing-first approach:

  • Advanced infrastructure designed for precision
  • Scalable production capabilities
  • Strict quality standards aligned with global expectations

This ensures that every batch delivered meets the same high standard trusted by pharmaceutical manufacturers worldwide.

More than a formulation choice it’s a strategic decision

For tablet manufacturers, choosing the right granule is not just a technical decision it’s a business one.

Directly compressible granules:

  • Reduce production complexity
  • Improve operational efficiency
  • Enhance product consistency
  • Accelerate time-to-market

And when backed by advanced manufacturing like GLATT technology, they become a true competitive advantage.

Looking to streamline your tablet production?

If your goal is to simplify processes, reduce costs, and improve consistency in analgesic tablet manufacturing, DC granules are the way forward.

Farmson’s Paracetamol DC range is designed to help you do exactly that with reliability you can trust and performance you can scale.

Let’s talk.
📩 connect@farmson.com
🌐 www.farmson.com